Contact:
Amanda Ascoli
Communications Associate
Society for Clinical Research Sites
410.696.5080 x120
amanda.ascoli@myscrs.org
FOR IMMEDIATE RELEASE
Ellicott City, M.D., February 5, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, has submitted an official comment on the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research. The SCRS Public Policy Community convened to compose the Society’s response, which recognizes the value of human research protections, including the Institutional Review Board (IRB) system in the U.S., and welcomes the implementation of a policy requiring the use of a single IRB. The comment focuses on addressing the various practicalities that must be considered to ensure the use of a single IRB will provide better quality and be sustainable for the long-term in the conduct of clinical trials.
SCRS President Christine Pierre states, “Submission of this comment is emblematic of SCRS upholding one of the foundational pillars of our organization: advocating on behalf of our membership. The organization’s first priority is to ensure that all policies affecting the conduct of clinical research are implemented as smoothly as possible with patient safety as the primary focus. The response that our Public Policy Community drafted succinctly expresses this, and SCRS thanks NIH for the opportunity to comment on this important initiative.”
SCRS’ response can be downloaded at this link. If you are interested in joining any SCRS community, please contact Amanda Ascoli, 410-696-5080 ext. 120.
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,000 research sites, including 26,000 research professionals; 15,000 investigators and 9,000 research staff, in 39 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at clinical research sites, will benefit from membership and partnership. Visit MySCRS.org.